NIFTY  9,604.90  0.10%
  SENSEX  31,109.30  0.26%
 CURRENCY  Rs  64.45/$ 72.07/€, 82.52/£
  GOLD  28,919.00  0.11%
  SILVER  40,360.00  0.67%
  DAX  12,629.00  0.21%
  FTSE  7,547.63  0.40%
  CAC  5,332.47  -0.07%
  HANG SENG  25,701.60  0.24%
  NIKKEI  19,682.60  -0.02%
  Shanghai Composite  3,110.06  0.04%
  DOW JONES  21,080.30  -0.01%
  NASDAQ  6,210.19  0.08%
  S&P 500  2,415.82  0.03%
EARNINGS REPORT - Jagran Prakashan To Pay Dividend Of Rs 3/Share EARNINGS REPORT - Jagran Prakashan Q4 Net Sales At Rs 455 Cr Vs Rs 425 Cr, Up 7% YoY

The Road Ahead For Cipla

Video:

Play this video

January 29: New patent laws in 1970s allowed domestic pharma firms such as Cipla to expand, explore and succeed through innovations, Accenture’s Sriram Shrinivasan says, winning India its fame as the pill factory of the world. Cipla Chairman Y.K. Hamied also speaks about his vision for the future, including ensuring that the current spirit of innovation and philanthropy is retained.